Literature DB >> 11213851

Relative bioavailability of lamotrigine chewable dispersible tablets administered rectally.

A K Birnbaum1, R L Kriel, Y Im, R P Remmel.   

Abstract

STUDY
OBJECTIVE: To determine the relative bioavailability of lamotrigine (LTG) chewable dispersible tablets after rectal administration.
DESIGN: Two-period, crossover study with a 2-week washout between dosing periods.
SETTING: Clinical research center. PATIENTS: Twelve healthy adult volunteers. INTERVENTION: One hundred milligrams of a LTG chewable dispersible tablet was administered by oral and rectal routes.
MEASUREMENTS AND MAIN RESULTS: Plasma samples were collected before and up to 120 hours after drug administration. The samples were analyzed for LTG by high-performance liquid chromatography, and the relative bioavailability was determined. Drug concentrations were lower after rectal than after oral administration. The relative bioavailability (F = AUC(rectal)/AUC(oral)) was 0.52 +/- 0.23 (SD).
CONCLUSION: Drug prepared from LTG chewable dispersible tablets is absorbed rectally, although not to the same extent as when given orally. Rectal administration of suspension of these tablets can be an acceptable route of administration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11213851     DOI: 10.1592/phco.21.2.158.34104

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  6 in total

Review 1.  Perioperative substitution of anti-epileptic drugs.

Authors:  Wilma S W Wichards; Alfred F A M Schobben; Frans S S Leijten
Journal:  J Neurol       Date:  2013-09-01       Impact factor: 4.849

2.  A Physiologically Based Pharmacokinetic Model for Optimally Profiling Lamotrigine Disposition and Drug-Drug Interactions.

Authors:  Todd M Conner; Ronald C Reed; Tao Zhang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-06       Impact factor: 2.441

3.  Relative bioavailability, metabolism and tolerability of rectally administered oxcarbazepine suspension.

Authors:  Pamela L Clemens; James C Cloyd; Robert L Kriel; Rory P Remmel
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

Review 4.  Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations.

Authors:  James W McAuley; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Incorporating Breastfeeding-Related Variability with Physiologically Based Pharmacokinetic Modeling to Predict Infant Exposure to Maternal Medication Through Breast Milk: a Workflow Applied to Lamotrigine.

Authors:  Cindy H T Yeung; Shinya Ito; Julie Autmizguine; Andrea N Edginton
Journal:  AAPS J       Date:  2021-05-17       Impact factor: 3.603

Review 6.  Practical Management of Epileptic Seizures and Status Epilepticus in Adult Palliative Care Patients.

Authors:  Wenke Grönheit; Stoyan Popkirov; Tim Wehner; Uwe Schlegel; Jörg Wellmer
Journal:  Front Neurol       Date:  2018-08-02       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.